From: Role of IQGAP3 in metastasis and epithelial–mesenchymal transition in human hepatocellular carcinoma
Clinical character | Variable | No. of patients (%) |
---|---|---|
Age (years) | ≤50 | 53 (44.2) |
>50 | 67 (55.8) | |
Gender | Female | 13 (10.8) |
Male | 107 (89.2) | |
Clinical stage | I | 48 (40.0) |
II | 44 (36.7) | |
III | 21 (17.5) | |
IV | 7 (5.8) | |
Cirrhosis | No | 58 (48.3) |
Yes | 62 (51.7) | |
T classification | T1 | 53 (44.2) |
T2 | 12 (10.0) | |
T3 | 6 (5.0) | |
T4 | 49 (40.8) | |
N classification | N0 | 97 (80.8) |
N1 | 23 (19.2) | |
M classification | M0 | 113 (94.2) |
M1 | 7 (5.8) | |
HCV | No | 119 (99.2) |
Yes | 1 (0.8) | |
HBsAg | Negative | 17 (14.2) |
Positive | 103 (85.8) | |
Vital status | Alive | 17 (14.2) |
Death | 103 (85.8) | |
IQGAP3 expression | Low expression | 68 (56.7) |
High expression | 52 (43.3) |